Bill Moore & his daughter Jessica Oberlin, two members of NAF, recently shared their stories of living with SCA3 as part of a feature for the Critical Path to Therapeutics for the Ataxias (CPTA). The CPTA aims to optimize clinical trials for inherited Ataxias. Impact stories like theirs can help researchers & drug developers understand the realities of living with Ataxia. You can read it here: CPTA — Impact Through Optimization of Clinical Trial Design | Critical Path Institute